Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET - PubMed (original) (raw)
Clinical Trial
Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET
Anthony K P Jones et al. Eur J Pain. 2004 Oct.
Abstract
Central neuropathic pain (CNP) is pain resulting from damage to the central nervous system. Up till now, it has not been possible to identify a common lesion or pharmacological deficit in these patients. This preliminary study in a group of patients with CNP with predominantly post-stroke pain, demonstrates that there is significantly less opioid receptor binding in a number of cortical and sub-cortical structures that are mostly, but not exclusively, within the medial pain system in patients compared to age-matched pain-free controls. The reductions in opioid receptor binding within the medial system were observed mainly in the dorsolateral (Brodman area 10) and anterior cingulate (Brodman area 24 with some extension into area 23) and insula cortices and the thalamus. There were also reductions in the lateral pain system within the inferior parietal cortex (Brodman area 40). These changes in binding could not be accounted for by the cerebral lesions shown by CT or MRI, which were outside the areas of reduced binding and the human pain system. To our knowledge this is the first systematic demonstration of a reduction in opioid receptor-binding capacity in neurones within the human nociceptive system in patients with CNP. This may be a key common factor resulting in undamped nociceptor activity within some of the structures that are predominantly within the medial nociceptive system. If confirmed, these findings may explain why certain patients with CNP require high doses of synthetic opiates to achieve optimum analgesia. The findings also raise the possibility of new pharmacological approaches to treatment.
Similar articles
- Differential brain opioid receptor availability in central and peripheral neuropathic pain.
Maarrawi J, Peyron R, Mertens P, Costes N, Magnin M, Sindou M, Laurent B, Garcia-Larrea L. Maarrawi J, et al. Pain. 2007 Jan;127(1-2):183-94. doi: 10.1016/j.pain.2006.10.013. Epub 2006 Nov 29. Pain. 2007. PMID: 17137714 - In vivo distribution of opioid receptors in man in relation to the cortical projections of the medial and lateral pain systems measured with positron emission tomography.
Jones AK, Qi LY, Fujirawa T, Luthra SK, Ashburner J, Bloomfield P, Cunningham VJ, Itoh M, Fukuda H, Jones T. Jones AK, et al. Neurosci Lett. 1991 May 13;126(1):25-8. doi: 10.1016/0304-3940(91)90362-w. Neurosci Lett. 1991. PMID: 1650933 - Motor cortex stimulation for pain control induces changes in the endogenous opioid system.
Maarrawi J, Peyron R, Mertens P, Costes N, Magnin M, Sindou M, Laurent B, Garcia-Larrea L. Maarrawi J, et al. Neurology. 2007 Aug 28;69(9):827-34. doi: 10.1212/01.wnl.0000269783.86997.37. Neurology. 2007. PMID: 17724284 Clinical Trial. - What to learn from in vivo opioidergic brain imaging?
Sprenger T, Berthele A, Platzer S, Boecker H, Tölle TR. Sprenger T, et al. Eur J Pain. 2005 Apr;9(2):117-21. doi: 10.1016/j.ejpain.2004.07.010. Eur J Pain. 2005. PMID: 15737798 Review. - Plasticity of nociception: recent advances in function-oriented structural pain research.
Knyihár E, Csillik B. Knyihár E, et al. Ideggyogy Sz. 2006 Mar 20;59(3-4):87-97. Ideggyogy Sz. 2006. PMID: 16634453 Review.
Cited by
- Experimental designs and brain mapping approaches for studying the placebo analgesic effect.
Colloca L, Benedetti F, Porro CA. Colloca L, et al. Eur J Appl Physiol. 2008 Mar;102(4):371-80. doi: 10.1007/s00421-007-0593-6. Epub 2007 Oct 25. Eur J Appl Physiol. 2008. PMID: 17960416 Review. - Decreased central mu-opioid receptor availability in fibromyalgia.
Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Harris RE, et al. J Neurosci. 2007 Sep 12;27(37):10000-6. doi: 10.1523/JNEUROSCI.2849-07.2007. J Neurosci. 2007. PMID: 17855614 Free PMC article. - Neuropathic Pain Induced Alterations in the Opioidergic Modulation of a Descending Pain Facilitatory Area of the Brain.
Costa AR, Carvalho P, Flik G, Wilson SP, Reguenga C, Martins I, Tavares I. Costa AR, et al. Front Cell Neurosci. 2019 Jun 28;13:287. doi: 10.3389/fncel.2019.00287. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31316354 Free PMC article. - Imaging non-dopaminergic function in Parkinson's disease.
Brooks DJ. Brooks DJ. Mol Imaging Biol. 2007 Jul-Aug;9(4):217-22. doi: 10.1007/s11307-007-0084-5. Mol Imaging Biol. 2007. PMID: 17340229 Review. - Can neuroimaging studies identify pain endophenotypes in humans?
Tracey I. Tracey I. Nat Rev Neurol. 2011 Mar;7(3):173-81. doi: 10.1038/nrneurol.2011.4. Epub 2011 Feb 8. Nat Rev Neurol. 2011. PMID: 21304481 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical